Not applicableUnknownNCT01044511What this trial is testingQuality of Life With Esophageal Stent TrialWho this might be right forEsophageal CancerGastro-esophageal Junction Cancer Michael Bau Mortensen 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07709767What this trial is testingConversion Therapy With Retlirafusp Alfa Plus Chemotherapy in Gastric or Gastroesophageal Junction AdenocarcinomaWho this might be right forGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma Tang-Du Hospital 21
Early research (Phase 1)Study completedNCT03849469What this trial is testingXmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid TumorsWho this might be right forMelanomaCervical CarcinomaPancreatic Carcinoma+20 more Xencor, Inc. 78
Early research (Phase 1)Study completedNCT02389751What this trial is testingGanetespib in Combination With Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-III Esophageal CancerWho this might be right forGastroesophageal Junction AdenocarcinomaMalignant Neoplasm of the Cervical EsophagusMalignant Neoplasm of the Thoracic Esophagus+5 more M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)Ended earlyNCT00080002What this trial is testingEfficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophageal JunctionWho this might be right forCancer of StomachGastroesophageal Cancer Enzon Pharmaceuticals, Inc.
Not applicableActive Not RecruitingNCT07429318What this trial is testingEfficacy and Survival Analysis of Perioperative Treatment of Locally Advanced Gastric or Gastroesophageal Junction CancerWho this might be right forLocally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma Cancer Institute and Hospital, Chinese Academy of Medical Sciences 300
Testing effectiveness (Phase 2)Study completedNCT07529613What this trial is testingTrastuzumab Deruxtecan Plus Nivolumab Plus Capecitabine Plus Oxaliplatin for HER2 Low Gastric and Gastroesophageal Junction AdenocarcinomaWho this might be right forGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma National Cancer Center Hospital East 30
Testing effectiveness (Phase 2)Looking for participantsNCT06947291What this trial is testingSafety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound) in Patients With Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid TumorsWho this might be right forAdvanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 350
Not applicableLooking for participantsNCT04958720What this trial is testingSpanish Registry of Esophagogastric CancerWho this might be right forEsophageal CancerGastric Cancer Fundación Sociedad Española de Oncologia Médica 10,000
Early research (Phase 1)Ended earlyNCT04144140What this trial is testingStudy of Intratumorally Administered Stimulator of Interferon Genes (STING) Agonist E7766 in Participants With Advanced Solid Tumors or Lymphomas - INSTAL-101Who this might be right forLymphomaAdvanced Solid Tumors Eisai Inc. 24
Testing effectiveness (Phase 2)Looking for participantsNCT06023758What this trial is testingPhase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GCWho this might be right forHER2-positive Locally Advanced Resectable Gastric Cancer Peking University 18
Testing effectiveness (Phase 2)Study completedNCT00940225What this trial is testingStudy of Cabozantinib (XL184) in Adults With Advanced MalignanciesWho this might be right forSolid TumorsCancer Exelixis 730
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06881017What this trial is testingEstablishment of Precision Targeted Therapy Strategies for Advanced Gastric Cancer Based on Novel Molecular SubtypingWho this might be right forGastric CancerHER2 + Gastric CancerCLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction+1 more China Medical University, China 140
Large-scale testing (Phase 3)Study completedNCT02578368What this trial is testingChemotherapy Alone vs. Chemotherapy + Surgical Resection in Patients With Limited-metastatic Adenocarcinoma of the Stomach or Esophagogastric JunctionWho this might be right forGastric Cancer Krankenhaus Nordwest 183
Testing effectiveness (Phase 2)Looking for participantsNCT07000253What this trial is testingTiming of Comprehensive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric AdenocarcinomaWho this might be right forEsophageal CancerGastric (Stomach) CancerGastric Adenocarcinoma+3 more Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 290
Testing effectiveness (Phase 2)Study completedNCT01983878What this trial is testingRamucirumab in Treating Japanese Participants With Metastatic Gastric or Gastroesophageal Junction CancerWho this might be right forGastric Cancer Eli Lilly and Company 36
Testing effectiveness (Phase 2)Study completedNCT00077545What this trial is testing3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal JunctionWho this might be right forAdenocarcinoma of the EsophagusRecurrent Esophageal CancerStage IV Esophageal Cancer National Cancer Institute (NCI) 39
Testing effectiveness (Phase 2)Looking for participantsNCT06330064What this trial is testingEvaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)Who this might be right forRecurrent or Metastatic Solid Tumors Daiichi Sankyo 680
Large-scale testing (Phase 3)Study completedNCT03615326What this trial is testingPembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)Who this might be right forGastric NeoplasmsGastroesophageal Junction Adenocarcinoma Merck Sharp & Dohme LLC 738
Not applicableStudy completedNCT02130011What this trial is testingDose-Guided Radiotherapy in Oesophageal Cancer: Managing the Real DoseWho this might be right forAdenocarcinoma Maastricht Radiation Oncology 20